A CASE REPORT WITH E6A2 BCR-ABL FUSION TRANSCRIPT WITH MARKED BASOPHILIA AND HIGH ACTIVATION OF SRC KINASES DOWNSTREAM BCR-ABL

被引：0
作者：
Divoka, M. [1 ]
Rohon, P. [2 ]
Calabkova, L. [3 ]
Mojzikova, R. [3 ]
Novosadova, A. [2 ]
Faber, E. [2 ]
Jarosova, M. [2 ]
Holzerova, M. [2 ]
Indrak, K. [2 ]
Divoky, V. [3 ]
机构：
[1] Fac Hosp, Olomouc, Czech Republic
[2] Univ Hosp, Olomouc, Czech Republic
[3] Palacky Univ, Fac Med, CR-77147 Olomouc, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1335
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [21] e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases
    Mondal, B. C.
    Majumdar, S.
    Dasgupta, U. B.
    Chaudhuri, U.
    Chakrabarti, P.
    Bhattacharyya, S.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (10) : 1102 - 1103
  • [22] The BCR-ABL fusion transcript type is different in one Mexican population.
    Rosas, A
    Ayala, M
    GonzalezLlaven, J
    Rodriguez, R
    Miranda, E
    Gariglio, P
    [J]. BLOOD, 1997, 90 (10) : 4013 - 4013
  • [23] CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
    Karolien Anne Beel
    Jan Lemmens
    Hilde Vranckx
    Johan Maertens
    Peter Vandenberghe
    [J]. Annals of Hematology, 2011, 90 : 1241 - 1243
  • [24] Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases
    Vefring, Hege K.
    Gruber, Franz X. E.
    Wee, Line
    Hovland, Randi
    Hjorth-Hansen, Henrik
    Dahl, Tobias Gedde
    Meyer, Peter
    [J]. ACTA HAEMATOLOGICA, 2009, 122 (01) : 11 - 16
  • [25] CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
    Beel, Karolien Anne
    Lemmens, Jan
    Vranckx, Hilde
    Maertens, Johan
    Vandenberghe, Peter
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1241 - 1243
  • [26] How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review
    Hu, Lin-Hui
    Pu, Lian-Fang
    Yang, Dong-Dong
    Zhang, Cui
    Wang, Hui-Ping
    Ding, Yang-Yang
    Li, Man-Man
    Zhai, Zhi-Min
    Xiong, Shudao
    [J]. ONCOLOGY LETTERS, 2017, 14 (05) : 5619 - 5623
  • [27] A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome
    Moreno, MD
    Cortinas, MN
    Bonomi, R
    Cardeza, A
    Uriarte, MD
    [J]. BLOOD, 2001, 97 (11) : 3668 - 3669
  • [28] ACTIVATION OF BCR-ABL FUSION GENE AND RAS ONCOGENES IN CHRONIC MYELOGENOUS LEUKEMIA
    FUTAKI, M
    INOKUCHI, K
    DAN, K
    NOMURA, T
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 163 - 169
  • [29] ImatinibDevelopment of resistance in BCR-ABL KD mutated patient: case report
    [J]. Reactions Weekly, 2016, 1590 (1) : 113 - 113
  • [30] An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation
    Jilani, Iman
    Kantarjian, Hagop
    Faraji, Homan
    Gorre, Mercedes
    Cortes, Jorge
    Ottmann, Oliver
    Bhalla, Kapil
    O'Brien, Susan
    Giles, Francis
    Albitar, Maher
    [J]. LEUKEMIA RESEARCH, 2008, 32 (06) : 936 - 943
12345